United States · FDA National Drug Code directory
Sumatriptan Succinate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 55111-291_3f0a2fa1-9b69-588d-f3f8-f2af5561edd0
- Product NDC
- 55111-291
- Form
- TABLET
- Composition / generic term
- Sumatriptan Succinate
- Labeler
- Dr. Reddy's Laboratories Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20091117
- Source listing expiry
- 20271231
Source-listed ingredients
- SUMATRIPTAN SUCCINATE — 25 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (55111-291-01) · 55111-291-01
- 500 TABLET in 1 BOTTLE (55111-291-05) · 55111-291-05
- 9 BLISTER PACK in 1 CARTON (55111-291-09) / 1 TABLET in 1 BLISTER PACK · 55111-291-09
- 30 TABLET in 1 BOTTLE (55111-291-30) · 55111-291-30
- 36 TABLET in 1 BOTTLE (55111-291-36) · 55111-291-36
- 90 TABLET in 1 BOTTLE (55111-291-90) · 55111-291-90
- 3 BLISTER PACK in 1 CARTON (55111-291-98) / 9 TABLET in 1 BLISTER PACK · 55111-291-98
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →